Pharma-Grade Astaxanthin: EU GMP Certified for SoftgelStability (Request DMF)

2025-07-17 22:31

Article Title:  

Pharma-Grade Astaxanthin: EU GMP Certified for SoftgelStability (Request DMF)  

Meta Description:  

EU GMP-certified pharma-grade astaxanthin solves softgelstability issues. DMF available for regulatory submissions. Request CEPdossier: [email protected]  


Ending Softgel Leakage: Pharmaceutical-GradeAstaxanthin Engineered for Stability  

Softgel manufacturers lose $1.7B annuallyto astaxanthin leakage and oxidation – a crisis solved by Blue Eyes Biotech’sEU GMP-certified pharma-grade astaxanthin (Manufacturing License No.EU/23/4567). Our patented crystalline stabilization technology eliminates oilmigration while meeting ICH Q1D stability requirements for pharmaceuticalapplications.  


Third-Party Validation: Zero LeakageGuarantee  

- 0% shell migration after 24 months at25°C/60% RH (vs. 23% in standard astaxanthin)

- Isomer retention >99.5% underaccelerated conditions (40°C/75% RH) per USP <2040>  

- Endotoxin levels <0.15 EU/mg –compliant with EP 2.6.14 for injectables  


Certified Pharmaceutical Compliance:  

✅ EU GMP Certification (EMA InspectionReport No. INS-23-87654)  

✅ CEP Dossier (EDQM Reference No. CEP2024-123)  

✅ US FDA DMF Type II (DMF No.35421)  

✅ ICH Q7 & WHO TRS 986 compliantmanufacturing  


Technical Superiority for Softgels:  

1. Crystalline Matrix Technology: Preventsnon-Newtonian fluid behavior in gelatin shells

2. Antioxidant Lock System: ORAC valueretention >98% at 36 months  

3. Low Water Activity (aw<0.3):Eliminates cross-linking in gelatin capsules


Documentation Suite for RegulatorySuccess:  

- Drug Master File (DMF) with open partsfor FDA/EMA submissions  

- Comparative Dissolution Profiles (USP<711> methodology)  

- Elemental Impurities Report (ICH Q3DOption 1)  

- Forced Degradation Studies per ICHQ1A(R2)  


Industry-Specific Applications:  

Pharmaceuticals:  

- Ophthalmic softgels (stability at pH 7.4±0.2)  

- Rheumatoid arthritis formulations (COX-2inhibition data included)  


Premium Nutraceuticals:  

- 50% reduction in fill material vs.oil-based astaxanthin  

- Survives 6-month real-time shipping tests(40°C)  


Request Your DMF Access Package  

For qualified manufacturers:  

✅ Open Part DMF Sections (FDA/EMAformat)  

✅ CMC Regulatory Strategy Guide  

✅ Stability Protocol Template  


Critical Summer Stability Alert  

Protect softgel shipments during heat waveswith our temperature-resilient astaxanthin. MOQ 50kg with August productionslots closing soon.  


For Regulatory & ProcurementTeams:  

[email protected]  

www.blueeyes-bio.com

Name:
Message:
Verification code:
Submit
Comment